Liver News and Research

RSS

Oil spill exposure appears to play role in development of hematologic and hepatic toxicity

A new study reports that workers exposed to crude oil and dispersants used during the Gulf oil spill cleanup display significantly altered blood profiles, liver enzymes, and somatic symptoms compared to an unexposed control group.

17 Sep 2013

Extreme binge drinking common among high school seniors

Consuming five or more alcoholic drinks in a row is common among high school seniors, with some students engaging in extreme binge drinking of as many as 15 or more drinks, according to a study published by JAMA Pediatrics, a JAMA Network publication.

17 Sep 2013

Researchers identify potentially treatable subtype of pancreatic cancer

Australian researchers have identified a potentially treatable subtype of pancreatic cancer, which accounts for about 2% of new cases. This subtype expresses high levels of the HER2 gene. HER2-amplified breast and gastric cancers are currently treated with Herceptin.

17 Sep 2013

Researchers identify new link between meal times and daily changes in immune system

A new link between meal times and daily changes in the immune system has been identified by UC San Francisco researchers, and has led them to question assumptions about the roles of specific immune cells in infection and allergy.

17 Sep 2013

New "app" from Henry Ford for cancer surgery patients

With a single tap on a smartphone, cancer patients now can access detailed information about treatment options by cancer type, GPS mapping to appointment locations, as well as schedule appointments and connect to their electronic medical record.

17 Sep 2013

Study: Healthy diet may reduce risk of severe depression

A healthy diet may reduce the risk of severe depression, according to a prospective follow-up study of more than 2,000 men conducted at the University of Eastern Finland. In addition, weight loss in the context of a lifestyle intervention was associated with a reduction in depressive symptoms.

16 Sep 2013

Drug used in patients for cancer treatment has beneficial effects on diabetes

A pair of studies by researchers at the Stanford University School of Medicine has identified a molecular pathway - a series of interaction among proteins - involved in the development of diabetes. Furthermore, they have found that a drug already approved for use in humans can regulate the pathway.

16 Sep 2013

Longer looks: Understanding the mind; facebook depression; planning for a successful end of life

Every week reporter Ankita Rao selects interesting reading from around the Web.

13 Sep 2013

Study: Higher rates of acute hepatitis C virus clearance are seen in women

A study of patients infected with acute hepatitis C virus (HCV) infection found that women had higher rates of spontaneous viral clearance—undetectable levels of the virus without initiating drug therapy.

13 Sep 2013

Supporting the Study of Healthy Aging through Biodevelopment

In this interview, Jacko Duker talks about the Lifelines Project, and how Panasonic ULT freezers have been employed to keep irreplaceable samples safe.

From PHC Europe B.V. 12 Sep 2013

Mount Sinai physician-scientists join DILIN to help find causes, diagnostics for drug-induced liver injury

In an effort to better understand and develop prevention strategies for drug-induced liver injury, physician-scientists from the Icahn School of Medicine at Mount Sinai have joined the Drug-Induced Liver Injury Network, a National Institutes of Health-funded consortium of only six academic medical centers in the United States.

12 Sep 2013

Wake Forest Baptist conducts $24 million project to accelerate development of new therapies

Whether it's the Ebola virus or Sarin and Ricin, a key to responding to chemical or biological attacks is having effective antidotes at the ready. To accelerate the development of new therapies, Wake Forest Baptist Medical Center's Institute for Regenerative Medicine is leading a unique $24 million federally funded project to develop a "body on a chip" that will be used to develop these countermeasures.

12 Sep 2013

New antibody could prevent Candida infections in patients who receive central lines

A team of researchers at Cincinnati Children's Hospital Medical Center has developed an antibody that could prevent Candida infections that often afflict hospitalized patients who receive central lines.

12 Sep 2013

Study shows fat transplantation may treat inherited metabolic diseases

Transplanting fat may treat such inherited metabolic diseases as maple syrup urine disease (MSUD) by helping the body process the essential amino acids that these patients cannot, according to Penn State College of Medicine researchers.

12 Sep 2013

Research shows smoking and obesity together may pose triple health threat

Millions of people who are obese and smoke tobacco may face additional health problems — including their responses to common prescription medicines — that extend beyond the well-known links with cancer, heart attacks and stroke, according to a report presented here today.

12 Sep 2013

Combination drug does not improve survival in patients with severe alcoholic hepatitis

Four weeks of treatment with a combination of the drug pentoxifylline and the corticosteroid prednisolone did not improve 6-month survival compared with prednisolone alone in 270 patients with severe alcoholic hepatitis, according to a study in the September 11 issue of JAMA.

11 Sep 2013

Causes of obesity, insulin resistance tied to fructose generated by the body

Researchers at the University of Colorado School of Medicine reported today that the cause of obesity and insulin resistance may be tied to the fructose your body makes in addition to the fructose you eat.

11 Sep 2013

Roche Signs Up To $422.5M Collaboration With Inovio

...

10 Sep 2013

Boehringer Ingelheim completes patient enrolment for interferon-free hepatitis C treatment

Boehringer Ingelheim today announced the completion of patient enrolment for a Phase IIa clinical trial investigating a new interferon-free, all-oral, direct-acting antiviral combination treatment for patients with genotype-1a chronic hepatitis C virus infection.

10 Sep 2013

Researchers develop TSUNAMI method to create animal model of adult-onset version of SMA

A research team at Cold Spring Harbor Laboratory has used a recently developed technology they call TSUNAMI to create the first animal model of the adult-onset version of spinal muscular atrophy, a devastating motor-neuron illness.

10 Sep 2013

Liver News and Research

Oil spill exposure appears to play role in development of hematologic and hepatic toxicity

Extreme binge drinking common among high school seniors

Researchers identify potentially treatable subtype of pancreatic cancer

Researchers identify new link between meal times and daily changes in immune system

New "app" from Henry Ford for cancer surgery patients

Study: Healthy diet may reduce risk of severe depression

Drug used in patients for cancer treatment has beneficial effects on diabetes

Longer looks: Understanding the mind; facebook depression; planning for a successful end of life

Study: Higher rates of acute hepatitis C virus clearance are seen in women

Supporting the Study of Healthy Aging through Biodevelopment

Mount Sinai physician-scientists join DILIN to help find causes, diagnostics for drug-induced liver injury

Wake Forest Baptist conducts $24 million project to accelerate development of new therapies

New antibody could prevent Candida infections in patients who receive central lines

Study shows fat transplantation may treat inherited metabolic diseases

Research shows smoking and obesity together may pose triple health threat

Combination drug does not improve survival in patients with severe alcoholic hepatitis

Causes of obesity, insulin resistance tied to fructose generated by the body

Roche Signs Up To $422.5M Collaboration With Inovio

Boehringer Ingelheim completes patient enrolment for interferon-free hepatitis C treatment

Researchers develop TSUNAMI method to create animal model of adult-onset version of SMA

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News